Enanta Pharmaceuticals Initiates Phase 1 Clinical Study of EDP-297, its Highly Potent and Targeted Follow-On Farnesoid X Receptor Agonist for the Treatment of Non-Alcoholic Steatohepatitis - The Baytown Sun
Mother's Intuition: A child's 'cold' turns life-threatening WTMJ-TV A typical cold turned out to be much more serious for one Kenosha family, but a mother's intuition might have saved her child's life.
Comments
Post a Comment